Effect of Omeprazole on Membrane P-Type ATPase and Peptide Transport in Helicobacter pylori

  • KI, MI-RAN (Graduate School of Biotechnology, Korea University) ;
  • SOON-KYU YUN (Graduate School of Biotechnology, Korea University) ;
  • SE-YOUNG HWANG (Graduate School of Biotechnology, Korea University)
  • Published : 1999.06.01

Abstract

We investigated the growth-inhibitory mechanism of Helicobacter pylori by omeprazole (OMP) and its activated sulfenamide (OAS). Using dithiothreitol (DTT) and 5,5'-dithio-bis[2-nitrobenzoic acid] (DTNB; Ellman's reagent), we first determined the relationship between the binding capacity of these compounds to H. pylori membrane and its significance to membrane P-type ATPase activity. After incubation of the intact H. pylori cells with either OMP or OAS, the residual quantity of free SH-groups on the cell membrane was measured, and, the resulting values were plotted as a function of time. From this experiment, we found that there was a considerable difference in the membrane-binding rates between OMP and OAS. At neutral pH, the disulfide bond formation on H. pylori membrane was completed within 2 min of incubation of the intact cells with OAS. By OMP, however, it was gradually formed, exceeding 10 min of incubation for completion, whereby, the extent of P-type ATPase inhibition appeared to be proportional to the disulfide forming rate. From this data, it was suggested that the disulfide formation might directly affect enzyme activity. Since OMP per se cannot yield a disulfide bond with cysteine, it is predicted that the enzyme inactivation must be caused by the OAS form. Accordingly, we postulated that, under the neutral pH, OMP could be converted to OAS in the course of transport. By extrapolating the inhibitory slopes, we could evaluate K₁ values, relating to their minimal inhibitory concentrations (MICs) for H. pylori growth. In these MIC ranges, H. pylori uptake or vesicular export of nutrients such as peptides were totally prohibited, but their effect in Escherichia coli were negligible. From these observations, we strongly suggest that the P-type ATPase activity is essential for the survival of H. pylori cells in particular.

Keywords

References

  1. Infect. Immun v.64 Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity Appelmelk, B.J.;S.I. Simoons.;R, Negrini;A.P.Moran;G. O. Aspinall;J. G. Forte;T. De Vries;H. Quan;T. Verboom;J.J. Maaskant;P. Ghiara;E.J. Kuipers;J.M. Crothers Jr.;M. A. Monteiro;A. Savio;J. De Graaff
  2. J. Bacteriol v.180 Properties of the P-type ATPases encoded by the coAP operons of Helicobacter pylori and Helicobacter felis Bayle, D.S.;Wangler, T.;Weitzenegger,;W. Steinhilber;J. Volz;M. Przybylski;K. P. Schafer;G. Sachs;K.Melchers
  3. Pharmacol v.50 Bismuth subcitrate and omeprazole inhibit Helicobacter pylori $F_1$-ATPase Beil, W.;C. Birkholz;S. Wagner;K.-F. Sewing
  4. Yale J. Biol. Med v.65 Progress with proton pump inhibition Bell, N. J.;R. H. Hunt
  5. Antimicrob. Agents Chemother v.39 Partial characterization and effect of omeprazole on ATPase activity in Helicobacter pylori by using permeabilized cells Belli, W. A.;J. Fryklund
  6. J. Biol. Chem v.272 Sites of reaction of the gastric H, K-ATPase with extracytoplasmic thiol reagents Besancon, M.;A. Simon;G. Sachs;J. M. Shin
  7. Arch. Biochem. Biophys v.128 A new method of peptide assay and the separation of three leucyl-glycinase of renal tissues Binkley, F.;F. Leibach;N. King
  8. J. Clin. Invest. v.100 Ecology of Helicobacter pylori in the human stomach Blaster, M. T.
  9. J. Physiol. Pharmacol v.48 Attachment of Helicobacter pylori strains to human epithelial cells Chmiela, M.;M. Lawnik;E. Czkwianianc;T. Rechcinski;I. Planeta-Malecka;T. Wadstrom;W. Rudnicka
  10. Annu. Rev. Med. v.43 Helicobacter pylori and gastroduodenal Cover, T. L.;M. J. Blaser
  11. J. Biol. Chem v.267 Purification and characterization of the vacuolating toxin from Helicobacter pylori Cover, T. L.;M. J. Blaser
  12. New Comprehensive Biochemistry v.21 Molecular aspects of transport proteins De Pont, J. J. H. H. M.;Neuberger, A(ed.);L. L. M. van Deenen(ed.)
  13. Annu. Rev. Biochem v.48 Membrane adenosine triphosphatase of prokaryotic cells Downie, J. A.;F. Gibson;G. B. Cox
  14. Nature v.384 no.Suppl.2 Glaxo Wellcome News
  15. J. Microbiol. Biotechnol v.6 Competitive spectrophotometry for microbial dipeptide transport systems Hwang, S.Y.;M. R. Ki.;S. Y. Cho;W. J. Lim;I. D. Yoo
  16. J. Microbiol. Biotechnol v.8 Purification and characterization of antistaphylococcal substance from Pseudomonas sp. KUH-001 Hwang, S.Y.;S. H. Lee;K. J. Song;Y. P. Kim;K. Kawahara
  17. J. Microbiol. Biotechnol. v.5 Phenylalanyl2-sulfanilyglycine as substrate for leucine aminopeptidase assay Hwang, S. Y.;S. Y. Cho;I. D. Yoo
  18. Anal. Biochem v.154 Determination of leucine aminopeptidase using phenylalanyl-3-thia-phenylalanine as substrate Hwang, S.Y.;W.D. Kingsbury;N, M. Hall;D. R. Jakas;G. L. Dunn;C. Gilvarg
  19. Pediatrics v.100 no.E3 Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children Kato, S.;J. Takeyama;K. Ebina;H. Naganuma
  20. Biochim. Biophys. Acta v.1143 ATP-driven potassium transport in right-side-out membrane vesicles via the Kdp system of Escherichia coli Kollman, R.;K. Altendorf
  21. Antimicrob. Agents Chemother v.30 Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents Lambert, T.;F. Megraud;G. Gebaud;P. Courvalin
  22. Pharmacol. Ther. v.69 The chemotherapeutic effects of $H^+/K^+$inhibitors on Helicobacter pylori infection Logan, R.P.
  23. Gastroenterol v.107 The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism McGowan, C. C.;T. L. Cover;M. J. Blaser
  24. Infec. Immun v.65 Analysis of $F_1F_0$-ATPase from Helicobacter pylori McGowan, C. C.;T. L. Cover;M. J. Blaser
  25. J. Biol. Chem. v.271 Cloning and membrane topology of a P-type ATPase from Helicobacter pylori Melchers, K.;T. Weitzenegger;A. Buhmann;W. Steinhilber;G. Sachs;K. P. Schafer
  26. Gastroenterol v.108 no.Suppl. A novel P-type ATPase cloned from Helicobacter pylori Melchers, K.;T. Weitzenegger;W. Steinhiber;G. Sachs
  27. J. Gen. Microbiol. v.139 Glucose utilization and lactate production by Helicobacter pylori Mendz, G. L.;S. L. Hazell;B. P. Burns
  28. N. Engl. J. Med. v.325 Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii Nomura, A.;G. N. Stemmermann;P.H. Chyou;I. Kato;G.I. Perez-Perez;M. J. Blaser
  29. J. Med. Microbiol. v.45 The vacuolar ATPase proton pump is present on intracellular vacuola induced by Helicobacter pylori Papini, E.;E. Gottardi;B. Satin;M. De Bernard;P. Massari;J. Telford;R. Pappuoli;S. B. Sato;C. Montecucco
  30. Infect. Immun. v.60 Characteristics of Helicobacter pylori variants selected for urease deficiency Perez-Perez, G. I.;A. Z. Olivares;T.L. Cover;M. J. Blaser
  31. N. Engl. J. Med v.324 Helicobacter pylori and peptic ulcer disease Peterson, W.L.
  32. Microbiol. v.140 Glucose metabolism by Helicobacter pylori Schaffer, G.;R. Stark;J. Greenman
  33. Acta Gastroenterol. Belg v.56 Factors affecting the antibacterial activity of omeprazole and structural analogs in vitro Sjostrom, J.-E.;M.-L. Berglund;J. Fryklund;T. Kuhler;H. Larsson
  34. Antimicrob. Agents Chemother v.421 Basis for the selective antibacterial activity in vitro of proton pump inhibitors against Helicobacter spp. Sjostrom, J. E.;T. Kuhler;H. Larsson
  35. J. Clin. Gastroenterol v.20 no.Sup.2 Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcers Sugiyama, T.;K. Hisano;T. Ochiai;N. Fujita;T. Kobayashi;T. Yabana;I. Kurokawa;A. Yachi
  36. J. Physiol. Pharmacol v.48 Biochemical aspects of Helicobacter pylori adhesion Wadstrom, T.;S. Hirmo;B. Nilsson
  37. Anal. Biochem. v.175 Investigation of the bicinchoninic acid protein assay: Identification of the groups responsible for color formation Wiechelman, K.;R. Braun;J. Fitzpatrick
  38. Biochem. Biophys. Res. Commun. v.40 On the reversibility of binding of cardiotonic steroids to a partially purified (Na/K)-activated adenosinetriphosphatase from beef brain Yoda, A.;L. E. Hokins
  39. J, Kor. Med. Sci. v.11 Pathogenesis and prevention of stomach cancer Youn, H. S.;G, H. Ko;M. H. Chung;W. K. Lee;M. J. Cho;K. H. Lee
  40. J. Microbiol. Biotechnol. v.7 Characteristics of ATPases present in everted membrane vesicles of Helicobacter pylori Yun, S.K.;S. Y. Hwang
  41. J. Micorbiol. Biotechnol. v.7 Expression of latent P-type ATPases and their presumptive roles in cell membrane of Helicobacter pylori Yun, S. K.;S. Y. Hwang